Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04020185
Title Safety and Efficacy Study of IMSA101 in Refractory Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.